Pharmacotherapy
Medical treatment using pharmaceutical drugs for symptoms, conditions, or prevention.
Pharmacotherapy, also known as pharmacological therapy or drug therapy, is a medical treatment that uses one or more pharmaceutical drugs to improve symptoms, treat underlying conditions, or prevent diseases. It is distinguished from surgical, radiation, physical, or other therapies, and in some contexts, medical therapy refers specifically to pharmacotherapy. The practice has evolved from ancient use of natural compounds and metals to modern evidence-based and personalized approaches, with rapid advancements in drug discovery over the last century.
- field
- Medical treatment using pharmaceutical drugs
- known_for
- Use of drugs for symptomatic relief, treatment, and prophylaxis; distinction from surgical and other therapies; evolution from natural remedies to rational drug design and personalized medicine
- key_concepts
- Evidence-based medicine, personalized medicine, pharmacogenetics, pharmacogenomics, medication compliance
Lore & Background
Natural remedies also appear in traditional Chinese medicine and Ayurvedic medicine. Tartar emetic was later used intravenously for schistosomiasis until replaced by praziquantel due to toxicity concerns. After World War II, pharmaceutical manufacturers surged, and drug discovery milestones—from antibiotics to biologics—occurred mostly in the last hundred years.
Reader's Guide
Pharmacotherapy's significance lies in its central role in modern medicine, evolving from empirical use of natural and metal compounds to a science grounded in evidence-based guidelines and personalized treatment. Personalized medicine considers factors like genetic variation, liver and kidney function, and age, with pharmacogenetics and pharmacogenomics studying inherited differences in drug metabolism and response. Medication compliance, or adherence, is also critical. The field continues to incorporate artificial intelligence in drug design to predict interactions and protein configurations.
A Journal Devoted to Lung Disease Treatment
Pulmonary Pharmacology & Therapeutics stands as a dedicated medical journal whose editorial mission centers on one specific intersection of medicine: the pharmacotherapy of lung diseases. Rather than casting a wide net across all areas of respiratory science or all branches of drug treatment, the publication narrows its focus to the research that explores how pharmaceutical agents are applied to conditions affecting the lungs. This targeted scope gives the journal a clear identity within the broader landscape of medical literature. It is published under the banner of Elsevier, one of the major names in academic and scientific publishing, which lends the outlet the institutional infrastructure and distribution channels that a research-focused medical journal requires. The very title signals to readers and researchers exactly where the journal sits at the crossroads of pulmonary medicine and therapeutic drug science, making it a natural destination for those tracking advances in how medications are developed, tested, and deployed against respiratory ailments.
From Founding to a Refined Identity
The journal did not arrive at its current name overnight. That nine-year gap between founding and renaming suggests a period during which the journal's editorial scope or self-conception was refined, broadened, or more precisely articulated. The addition of 'Therapeutics' to the title underscores a deliberate emphasis on the practical, treatment-oriented dimension of the research it carries, not merely the pharmacological mechanisms behind drugs. For anyone tracing the history of respiratory medicine publishing, this two-stage naming journey is a small but telling detail: it marks a publication that was still defining its editorial voice in its first decade, and that by the late 1990s had settled into the identity it carries to this day.
The Elsevier Connection
Behind the editorial content of Pulmonary Pharmacology & Therapeutics sits the publishing machinery of Elsevier, a name that carries considerable weight in the world of academic and scientific literature. The relationship between a specialized medical journal and a large-scale publisher like Elsevier is one of infrastructure: the publisher provides the production, distribution, and digital hosting frameworks that allow researchers' work to reach a global audience. For a journal focused on the pharmacotherapy of lung diseases, this partnership means that the studies, reviews, and investigations it carries are channeled through one of the most recognized names in scholarly publishing. The journal's classification as a medical journal further situates it within the broader ecosystem of clinical and biomedical periodicals, where peer review and rigorous editorial standards are the norm. Elsevier's role is not to dictate the science but to ensure that the science, once vetted, is reliably delivered to the clinicians, pharmacologists, and pulmonologists who depend on staying current in a fast-moving therapeutic field.
A Living Publication Spanning Decades
The existence of an official website for the journal is a small but meaningful detail in the modern publishing landscape: it signals that the publication has a dedicated digital home where researchers, clinicians, and students can access its content, learn about its scope, and engage with the work it carries. In a field where new drugs, new delivery mechanisms, and new therapeutic strategies for lung conditions are constantly emerging, a journal that has been publishing since the late 1980s represents a long-running record of progress, a steady reference point for anyone following how pharmaceutical science intersects with pulmonary care.
Frequently Asked Questions
What is Pharmacotherapy in the Pharmacology And Therapeutics canon?
Pharmacotherapy is the drug-based arm of medical treatment, using one or more pharmaceutical agents to relieve symptoms, address the underlying cause of a disease, or prevent future illness. It is the go-to modality when a clinician reaches for a molecule rather than a scalpel or a beam of radiation.
How does Pharmacotherapy differ from surgical or radiation therapy?
Where surgery and radiotherapy physically alter tissue, pharmacotherapy works through chemical interaction—molecules engineered to hit specific biological targets. In many hospital settings the phrase 'medical therapy' is used as a shorthand that refers exclusively to this drug-based approach.
What key concepts do fans of the series keep referencing?
The recurring pillars are evidence-based prescribing, personalized medicine, pharmacogenetics, pharmacogenomics, and the practical challenge of keeping patients on their regimens. Together they define how a prescriber selects the right agent, dose, and schedule for a given individual.
How did Pharmacotherapy evolve from ancient remedies to modern practice?
The story begins with empirical use of plant extracts and metallic compounds, then shifts toward rational design once molecular targets became identifiable. The past hundred years brought an explosion in discovery pipelines, culminating in today's genomics-informed, individually tailored regimens.
Why is Pharmacotherapy considered the backbone of modern therapeutics?
Because the overwhelming majority of both chronic and acute conditions—hypertension, infections, malignancies, autoimmune disorders—are managed primarily through carefully chosen medications rather than operative intervention. It sits as the default first-line strategy in most treatment algorithms a clinician encounters.
More in Pharmacology And Therapeutics 1-19
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record